Recently, biopsy-proven thrombotic microangiopathy and focal glomerulosclerosis were reported in patients with IFNβ-associated nephropathy (Dauvergne et al., 2021). This evidence concerns the gene IFNB1 and Genetic thrombotic microangiopathy.